Your browser doesn't support javascript.
loading
Tetrahydrocurcumin Add-On therapy to losartan in a rat model of diabetic nephropathy decreases blood pressure and markers of kidney injury.
Khazaeli, Mahyar; Nunes, Ane C F; Zhao, Yitong; Khazaali, Mahziar; Prudente, John; Vaziri, Nosratola D; Singh, Bhupinder; Lau, Wei Ling.
Afiliación
  • Khazaeli M; Pathology Department, University at Buffalo, Buffalo, New York, USA.
  • Nunes ACF; Division of Nephrology, Department of Medicine, University of California, Irvine, California, USA.
  • Zhao Y; Division of Nephrology, Department of Medicine, University of California, Irvine, California, USA.
  • Khazaali M; Division of Nephrology, Department of Medicine, University of California, Irvine, California, USA.
  • Prudente J; Division of Nephrology, Department of Medicine, University of California, Irvine, California, USA.
  • Vaziri ND; Division of Nephrology, Department of Medicine, University of California, Irvine, California, USA.
  • Singh B; Division of Nephrology, Department of Medicine, University of California, Irvine, California, USA.
  • Lau WL; Division of Nephrology, Department of Medicine, University of California, Irvine, California, USA.
Pharmacol Res Perspect ; 11(2): e01079, 2023 04.
Article en En | MEDLINE | ID: mdl-36971089
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Insuficiencia Renal Crónica Tipo de estudio: Clinical_trials Límite: Animals Idioma: En Revista: Pharmacol Res Perspect Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Nefropatías Diabéticas / Insuficiencia Renal Crónica Tipo de estudio: Clinical_trials Límite: Animals Idioma: En Revista: Pharmacol Res Perspect Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos